51

DAFTAR PUSTAKA

Aggarwal A.N et al., 2010. Prevalence and Risk Factors for Bronchial Asthma in

Indian Adults: A Multicentre Study. The Indian Journal of Chest

Diseases & Allied Sciences. Vol: 4.

Alomar MJ. Factors affecting the development of adverse drug reactions. Saudi

Pharm J. 2014;(22):83-94.doi:10.1016/j.jpa

Alsagaff H, Mukti H.A., 2009. Dasar-Dasar Ilmu Penyakit Paru. Surabaya:

Airlangga University pp.264.

American Lung Association (ALA).(2015a).Asthma.Retrieved from

http://www.lung.org/association/states/colorado/asthma/asthma.html.

Badan Pengawas Obat dan Makanan (BPOM). Peraturan Kepala Badan Pengawas

Obat danMakanan Republik Indonesia Nomor HK.03.1.23.12.11.10690

tahun 2011 Tentang Penerapan Farmakovigilans Bagi Industri Farmasi.

2011

Barreto ML, Ribeiro-Silva Rde C, Malta DC, Oliveira-Campos M, Andreazzi

MA, Cruz AA. Prevalence of asthma symptoms among adolescents in

Brazil: National Adolescent School-based Health Survey (PeNSE 2012).

Revista Brasileira de Epidemiologia 2014;17 Suppl 1:106-15

Baxter K .ed. Stockley’s Drug Interactions. Pharmaceutical Press. 2008

Castro M, Rubin AS, Laviolette M, et. al. Effectiveness and safety of bronchial

thermoplasty in the treatment of severe asthma: a multicenter,

randomized, double-blind, sham-controlled clinical trial. Am J Respir

Crit Care Med. 2010; 181:116-24.

Chauhan BF, Ducharme FM.Addition to inhaled corticosteroids of long-acting

beta 2-agonist versus anti leukotrienes for chronic asthma. Cochrane

Database Syst Rev 2014;1;CD003137

Chapman KR et al.,2008 Sub Optimal Asthma Control: Revalence,Detection, and

Consequences in General Practice. J Respir Indo Vol. 31, No. 2, April

2011 60 Europan Respiratory Journal. 31: 320-5.

Chung KF.New treatments for severe treatment-resistant asthma: targeting the

right patient. Lancet Respire Med 2013;1:639-52

Cochrain G.M., Clark JH., 1975. A Survey of Asthma Mortality in Patients

Between Ages 35 and 64 in the Greater London Hospitals in 1971.

Thorax 30:300-305.

52

Departemen Kesehatan R,I, 2008, Pharmaceutical Care Untuk Penyakit

Hipertensi,Direktorat Bina Farmasi Komunitas Dan Klinik Departemen

Kesehatan RI,Jakarta, Diakses tanggal 5 Maret 2017. Direktorat Jenderal

Pengendalian Penyakit dan Penyehatan Lingkungan

Departemen Kesehatan Republik Indonesia, 2009, Keputusan menteri kesehatan

RI Nomor 1023/MENKES/SK/XI/2008 tentang pedoman pengendalian

penyakit asma. Jakarta: Departemen Kesehatan Republik Indonesia

Dinas Kesehatan., 2009. Profil Kesehatan Provinsi Jawa Tengah.

http://www.dinkesjatengprov.go.id/dokumen/profil/2009/Profil_2009br.p

df.Diakses tanggal 27 Maret 2013.

Doherty, M.J., 2009, Algorithms for assessing the probability of an Adverse drug

reaction. Journal Home page

Fitriani F., Yunus F., Rasmin M., 2011. Prevalence of Asthma In a Group of 13-

14 Years Old Students Using The ISAAC Written Questionnaire and

Bronchial Provocation Test in South Jakarta. Jurnal Respirologi

Indonesia. 31:2.

Global Initiative for Asthma (GINA). 2017, National Heart Lung and Blood

Institute.

Global Initiative for Asthma (GINA). 2015, Global strategy for asthma

management and prevention. [cited 2015 Jan 23].

Hassan A, Riad N, & Ahmed F.(2012).Effect of Buteyko breathing techniques on

patients with bronchial asthma.Egyption Journal of Chest Disease And

tuberculosis,61(4),235-41.

Horn J, Hansten PD. 2007, Drug Interation: Insights and Observations: DIPS: A

Tool to Evaluate Causation in Potential Drug Interactions. Pharmacy

Times.

Huang L, Chen Q, Ahao Y,Wang W,Fang F,& Bao Y. (2015).Is elective Cesarean

section assosiated with a higher risk of asthma? A meta-analysis. The

Journal Asthma,52(1),16-25

Husein A.N, Kumar V., 2010. Paru, dalam : Dasar Patologi Penyakit. Edisi

7.Jakarta : EGC hal. 742 45.

Hood A., Mukty A., 2010. Dasar-dasar Ilmu Penyakit Paru. Surabaya :Airlangga

University Press hal. 263-93.

Ikawati, Z., 2006. Pengantar Farmakologi Molekuler.Gadjah Mada University

Press

53

Jose BP, Camargos PA, Cruz Filho AA, Correa Rde A. Diagnostic accuracy of

respiratory diseases in primary health units. Rev Assoc Med Bras

2014;60:599-612.

Kaneshiro N.(2014). Asthma. Retrieved from

http://www.nlm.nih.gov/medlineplus/ency/article/000141.htm

Kasiulevicius V, Sapoka V, Filipaviciute R. Theory and Practice: 2009 Sample

Size Calculation In Epidemiological Studies. Gerontologija. 2006; 7(4):

225–231 Kedokteran Universitas Indonesia.

Keputusan Menteri Kesehatan RI No. 312/MENKES/SK/IX/2013 tentang Daftar

Obat Essensial (DOEN). 2013

Kline,G.S.,2013. Asthma Control Test. http://www.asthma.com/resources/asthma-

control-test.html.

Laxman, Vikas., 2010. Cliniciphysio Pathological Correlation and Management of

Nocturnale Asthma on Rural Areas.Rajiv Gandhi University. Disertation.

Livio F, Renard D, Buclin T 2012 Pharmacovigilance. Rev Med Suisse 8:116-

119.

Lugogo NL, MacIntyre NR.Life-Threatening Asthma: Pathophysiology and

Management. RespiratoryCare. 2008 June;53(6):726-739

MacDonald TM, et al. 2010. As-sociation of upper gastrointes-tinal toxicity of

nonsteroidal anti-inflammatory drugs with continued exposure: cohort

study. British Medical Journal;315: 1333-7.

Maranatha D., 2010. Asma Bronkial, dalam : Buku Ajar Ilmu Penyakit Paru.

Surabaya : FK UNAIR hal. 55-73.

Marklund B, Tunsater A, Bengtsson C. How often is the diagnosis bronchial

asthma correct? Fam Pract 2013;16:112-6.

National Asthma Council Australia.Asthma Management Handbook. 2010.

Website:http://www.nationalasthma.org.au/uploads/handbook/370-

amh2010_web_5.pdf.

Naranjo CA, U Busto, et al. 2010. A method for estimating theprobability of

adverse drug re-actions. Clinical Pharmacology and Therapeutics; 30(2):

239-45.

National Heart,Lung,and Blood Institute(NHLBI).2014b.what are the signs and

symptoms of asthma? Retrieved from

http://www.nhlbi.nih.gov/health/health-topics/topics/asthma/signs

54

National Institute of Health, NHLBI. Buerden of asthma. In: Global initiative for

asthma. Bethesda: National Institutes of Health. 2005.p.11-5.

Nelson HS, Weiss ST, Bleecker ER, Yancey SW, Dorinsky PM. The Salmeterol

Multicenter Asthma Research Trial: a comparison of usual

pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol.

Chest. 2006;129(1):15-26

Notoatmodjo S., 2010. Metodologi Penelitian Kesehatan. Jakarta : Rineka Cipta

hal. 37-38:124

O'Byrne PM, Reddel HK, Eriksson G, et al. Measuring asthma control: a

comparison of three classification systems. Eur Respir J 2010;36:269-76

Oemiati R, Sihombing M, Qomariah. Faktor-faktor yang Berhubungan dengan

Penyakit Asma di Indonesia. Media Litbang Kesehatan. 2010;20(1):41-

49

Patel M, Pilcher J, Reddel HK, et al. Metrics of salbutamol use as predictors of

future adverse outcomes in asthma. Clin Exp Allergy 2013;43:1144-51.

Pawankar R,(2014).Allergic diseases and asthma:a global public health concern

and a call to action.world Allergy Organization

Journal,7(12).doi:10.1186/1939-4551-12.

PDPI (Perhimpunan Dokter Paru Indonesia). ASMA. Pedoman Praktis Diagnosis

dan Penatalaksanaan di Indonesia. Revisi 2010.

Rab T., 2010. Ilmu Penyakit Paru. Jakarta : Trans Info Media hal. 377-90.

Rahmawati I, Yunus F, Wiyono WH. Pathogenesis dan patofisiologis asma,

majalah Cermin Dunia Kedokteran 2003;141;p.5-ll

Rank MA, Hagan JB, Park MA, et al. The risk of asthma exacerbation after

stooping low-dose inhaled corticosteroids: a systematic review and meta-

analysis of randomized controlled trials. J Allergy Clin Immunol

2013;131;724-9

Ray A, Gulati K, Tyagi N, Vishnoi G, Lal D, Vijyan VK. Pharmacovigilance in

respiratory medicine: An experience with theophylline. Indian J

Pharmacol. 2008; 40(2): S206-207

Rengganis, Iris., 2008. Diagnosis dan Tatalaksana Asma. Majalah Kedokteran

Indonesia. 58(11).

Sundaru H. (2009). Asma: apa dan bagaimana pengobatannya. Jakarta: Fakultas

55

Taylor DR, Bateman ED, Boulet LP, Boushey HA, Busse WW, Casale TB, et al.

A new perspective on concepts of asthma severity and control. Eur

Respir J 2008;32:545-54.

The Uppsala Monitoring Centre, 2000 Safety Monitoring of Medicinal Products:

Guidelines for Setting-up and Running a Pharmacovigilance Centre,

Sweden, WHO Collaborating Centre for International Drug Monitoring.

Thomas A, Lemanske RF,Jr.,Jackson DJ. Approaches to stepping up and stepping

down care in asthmatic patients. J Allergy Clin Immunol 2011;128;915-

24

Turkoski, B. B., Brenda R. L., dan Elizabeth A. T., 2011, Drug Information

Handbook for Nursing, Ohio, Lexi-comp.

Tyagi N, Gulati K, Vijayan VK, Ray A. A Study to Monitor Adverse Drug

Reactions in Patients of Chronic Obstructive Pulmonary Disease: Focus

on Theophylline. The Indian Journal of Chest Diseases & Allied

Sciences. 2008;50:199-202

Tse SM, Tantisira K, Weiss ST. The Pharmacogenetics and Pharmacogenomics of

Asthma Therapy. Pharmacogenomics Journal. 2011 Dec;11(6):383-392

Vuillermin P, South M, Robertson C. Parent -initiated oral corticosteroid therapy

for intermittent wheezing illnesses in children. Cochrane Database Syst

Rev 2006:CD005311

Wang, Xiaojia., 2010. Circadian Activation of Mast Cell Mediates the Nocturnal

Response in Allergic Asthma. The Faculty the Departement of

Physiology Brody School of Medicine at East Carolina University.

Disertation.

Ward, J.P.T., Ward, J., Leach R.M., and Wiener, C.M., 2008, At a Glance: Sistem

Respirasi Edisi Kedua, EMS, Jakarta.

Word Health Organization., 2013. Asthma Cronic Respiratory Disseases.

http://www.who.int/respiratory/asthma/en/. Diakses tanggal 24 April

2013.

Yunus F.,2012. The Asthma Control Test, A new tool to improve the quality of

asthma management.Dalam: Suryanto E, Suradi, Reviono, Rima

A,Widysanto A, Widiyawati, editors. Preceeding Book Perhimpunan

Dokter Paru Indonesia. 1st ed. Surakarta: Indah Comp. 361.